NARROW MARGIN

Clinical trials for NARROW MARGIN explained in plain language.

Never miss a new study

Get alerted when new NARROW MARGIN trials appear

Sign up with your email to follow new studies for NARROW MARGIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo therapy aims to stop aggressive liver Cancer's return

Disease control Recruiting now

This study is for people who had surgery for liver cancer but are at high risk of it coming back. It compares two different follow-up treatments to see which is better at keeping the cancer away. One group gets a combination of targeted radiation and an immunotherapy drug. The ot…

Matched conditions: NARROW MARGIN

Phase: PHASE3 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

NARROW MARGIN

Get alerted when new NARROW MARGIN trials appear

New combo therapy aims to stop aggressive liver Cancer's return